dihydroethidium has been researched along with gw9662 in 1 studies
| Studies (dihydroethidium) | Trials (dihydroethidium) | Recent Studies (post-2010) (dihydroethidium) | Studies (gw9662) | Trials (gw9662) | Recent Studies (post-2010) (gw9662) |
|---|---|---|---|---|---|
| 308 | 3 | 99 | 617 | 0 | 406 |
| Protein | Taxonomy | dihydroethidium (IC50) | gw9662 (IC50) |
|---|---|---|---|
| Peroxisome proliferator-activated receptor gamma | Homo sapiens (human) | 3.3 | |
| Nuclear receptor ROR-gamma | Homo sapiens (human) | 0.086 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asanuma, K; Fukami, K; Ishibashi, Y; Matsui, T; Nakamura, K; Ohta, K; Okuda, S; Takeuchi, M; Tanoue, R; Yamagishi, S | 1 |
1 other study(ies) available for dihydroethidium and gw9662
| Article | Year |
|---|---|
PEDF inhibits AGE-induced podocyte apoptosis via PPAR-gamma activation.
Topics: Anilides; Animals; Apoptosis; Cattle; Cell Differentiation; Ethidium; Eye Proteins; Gene Expression Regulation; Glycation End Products, Advanced; Glycoproteins; Mice; Nerve Growth Factors; Neurons; Podocytes; PPAR gamma; RNA, Messenger; Serpins; Serum Albumin, Bovine; Transcription, Genetic; Up-Regulation | 2013 |